Alex Georgiou

Very proud of the clinical research presented by @GSTTnhs Lung Cancer team at #BTOG26. Congratulations to Dr Holdich who showcased our work in lung cancer in never smokers and won first prize for poster presentation. 👏👏@spyrosgennatas @DrDanielJHughes @GuysCancerC

We’re delighted so many of our community could come & share the day with us at our London EGFR+ UK #LungCancer Conference yesterday. Sara captured it perfectly afterwards: “Excellent to hear from Dr Alex Georgiou. Really interesting, useful & clearly explained. Thank you. It was also lovely to hear from LCCNS Jo Wick, who shared her passion for her role & care of her patients.” Thank you to everyone who came, shared their experiences, & made it such a good day. We hope you enjoyed it as much as we did. 📷 & words shared by @SaraTurle 🙏 #EGFRpositive #LungCancer #LCSM

Link to full article #LCSM mdpi.com/1718-7729/32/1…

Pleased to see that this article is now published: Malgnant SVCO stenting outcomes and complications Guys Cancer Centre London real world experience: Endovascular stenting is effective; we report a high thrombosis risk and we review anticoagulation practice

I am very pleased to have contributed to this excellent The Guardian article to raise awareness on lung cancer in never-smokers. theguardian.com/society/2025/s… Our ongoing lung cancer in never smoker research supported by @GuysCancerC and Everybreath lung cancer charities was quoted

Raising awareness on lung cancer in never smokers is crucial

The Guys cancer centre SE london, lung cancer in never smoker epidemiological research that we presented in ELCC and ESMO 2023 were used in this article in Mail on Sunday published on 22 June. Thank you to @GuysCancerC and everybreath.org charity for support

@tnewsomdavis Krystal 7 (pembro vs pembro+adagrasib in PDL>50%) and also Krystal 4 (carbo-pem-pembro vs carbo-pem-pembro- Adagrasib) are both open and recruiting at Guy’s and St Thomas.

KRYSTAL-7: Ada + Pembro, KRAS G12C NSCLC, Ph2 ✅ORR 44% ITT, 61% PD-L1 >50% ✅mPFS 11.0m ITT, 26.7m PD-L1 hi 🔹 By comparison, Pembro 7-8m, chemoIO 9m ✅mOS 18.3m, NR PD-L1 hi ❗️60% Gr3+ TRAE: GI & liver ❗️High dose redn & interr Active, AEs common, Ph3 ongoing #LCSM #ASCO25

It was an honour to be invited to be a part of the ITV1 Tonight programme on young patients with cancer. Thank you to all patients that contributed to this to raise awareness.

Excellent multidisciplinary work displayed by Guys @GSTTnhs Thoracic Malignancies team at #BTOG25 posters: Neoadjuvant chemoIO, SABR, AHP OPD Screening tool, dietetic OPD interventions in lung cancer @BTOGORG

EGFR-M+ Advanced NSCLC. Ami/laz or Chemo-Osi. What to do? @Alex__Georgiou asked @EgfrUk and received mixed responses per slide. More work needed on pt selection strategies. #BTOG25 @BTOGORG

@Yvonne_Diaz_ @BTOGORG @EgfrUk @Roy_Castle_Lung @RuthStraussFdn @GSTTnhs Very grateful to @EgfrUk for providing this data

Dr @Alex__Gerogiou showcases big advancements in EGFR #Lungcancer care @BTOGORG. Big question is: which treatment is best for the individual? Data is key but so is patient involvement - as corroborated with data from @EGFRuk #BTOG25 #LCSM

@PatelOncology @JessicaJLinMD Excellent presentation by @JessicaJLinMD . Congratulations

Nice presentation on 1L ALK space by @JessicaJLinMD #ASCO2024, #MedIQASCO2024

NGS on formalin-free fresh EBUS: ✅ 99% RNA sequencing success ✅ 100% DNA sequencing success ✅ 100% concordance with fixed samples 🔺 Only 42% sequencing success with fixed samples Great work from @GSTTnhs and SE London GLH #LCSM #BTOG24

A few spaces left at our ctDNA webinar on Jan 30th Join @Alex__Georgiou from @GSTTnhs plus #oncology experts from @RoyalSurrey & @StGeorgesTrust to hear more about our pilot with #lung cancer patients. It's CPD accredited too..😉 Sign up bit.ly/ctDNAlungcancer #ThinkGenomics

@DrDanielJHughes @GSTTnhs @myESMO @GuysCancerC @KingsImaging @Kings_HSDTC @ProfVickyGoh @EKarapanagiotou

@GSTTnhs Cancer showing up today with 2 posters in Early Stage NSCLC section at @myESMO 💪🏻 Some great interest and discussion from research being conducted at Guys Cancer @GuysCancerC @KingsImaging @Kings_HSDTC #ESMO2023 @Alex__Georgiou @ProfVickyGoh @EKarapanagiotou

Join #ESMO23 poster- Lung cancer in never smokers real-world outcomes from SE London-Guy’s cancer centre. LCINS affects all ethnic groups. New strategies for earlier stage diagnosis needed.Thank you @GuysCancerC everybreath.org.uk